Healthstream Inc (HSTM)

$25.7064

+0.4

(+1.57%)▲

Market is closed - opens 8 PM, 05 Dec 2023

Insights on Healthstream Inc

  • Increasing Revenue

    Revenue is up for the last 9 quarters, 64.09M → 70.33M (in $), with an average increase of 1.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 4.13M → 3.86M (in $), with an average decrease of 6.4% per quarter

  • Vs TXG

    In the last 1 year, 10x Genomics Inc has given 17.4% return, outperforming this stock by 18.4%

Performance

  • $25.02
    $25.76
    $25.71
    downward going graph

    2.7%

    Downside

    Day's Volatility :2.89%

    Upside

    0.19%

    downward going graph
  • $20.42
    $27.57
    $25.71
    downward going graph

    20.58%

    Downside

    52 Weeks Volatility :25.93%

    Upside

    6.75%

    downward going graph

Returns

PeriodHealthstream IncSector (Health Care)Index (Russel 2000)
3 Months
20.07%
-1.3%
0.0%
6 Months
7.66%
1.2%
0.0%
1 Year
0.84%
-5.7%
-6.5%
3 Years
26.8%
17.1%
-6.5%

Highlights

Market Capitalization
781.4M
Book Value
$11.19
Dividend Share
0.075
Dividend Yield
0.39%
Earnings Per Share (EPS)
0.43
PE Ratio
60.0
PEG Ratio
6.85
Wall Street Target Price
24.0
Profit Margin
4.72%
Operating Margin TTM
6.91%
Return On Assets TTM
1.92%
Return On Equity TTM
3.89%
Revenue TTM
277.0M
Revenue Per Share TTM
9.04
Quarterly Revenue Growth YOY
4.5%
Gross Profit TTM
175.7M
EBITDA
36.3M
Diluted Eps TTM
0.43
Quarterly Earnings Growth YOY
0.05
EPS Estimate Current Year
0.44
EPS Estimate Next Year
0.47
EPS Estimate Current Quarter
0.09
EPS Estimate Next Quarter
0.09

Analyst Recommendation

Buy
    63%Buy
    36%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Healthstream Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
4
4
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Downside of 6.64%

Current $25.71
Target $24.00

Company Financials

FY17Y/Y Change
Revenue
247.7M
↑ 9.6%
Net Income
10.0M
↑ 166.42%
Net Profit Margin
4.04%
↑ 2.38%
FY18Y/Y Change
Revenue
231.6M
↓ 6.48%
Net Income
32.2M
↑ 222.04%
Net Profit Margin
13.91%
↑ 9.87%
FY19Y/Y Change
Revenue
254.1M
↑ 9.71%
Net Income
15.8M
↓ 51.05%
Net Profit Margin
6.21%
↓ 7.7%
FY20Y/Y Change
Revenue
244.8M
↓ 3.65%
Net Income
14.1M
↓ 10.65%
Net Profit Margin
5.76%
↓ 0.45%
FY21Y/Y Change
Revenue
256.7M
↑ 4.85%
Net Income
5.8M
↓ 58.52%
Net Profit Margin
2.28%
↓ 3.48%
FY22Y/Y Change
Revenue
266.8M
↑ 3.94%
Net Income
12.1M
↑ 106.86%
Net Profit Margin
4.53%
↑ 2.25%
Q2 FY22Q/Q Change
Revenue
65.6M
↑ 0.41%
Net Income
3.1M
↑ 6.57%
Net Profit Margin
4.7%
↑ 0.27%
Q3 FY22Q/Q Change
Revenue
67.3M
↑ 2.51%
Net Income
3.7M
↑ 18.91%
Net Profit Margin
5.45%
↑ 0.75%
Q4 FY22Q/Q Change
Revenue
68.5M
↑ 1.86%
Net Income
2.5M
↓ 33.14%
Net Profit Margin
3.58%
↓ 1.87%
Q1 FY23Q/Q Change
Revenue
68.9M
↑ 0.6%
Net Income
2.6M
↑ 7.02%
Net Profit Margin
3.8%
↑ 0.22%
Q2 FY23Q/Q Change
Revenue
69.2M
↑ 0.37%
Net Income
4.1M
↑ 57.57%
Net Profit Margin
5.97%
↑ 2.17%
Q3 FY23Q/Q Change
Revenue
70.3M
↑ 1.65%
Net Income
3.9M
↓ 6.44%
Net Profit Margin
5.5%
↓ 0.47%
FY17Y/Y Change
Total Assets
411.1M
↑ 3.81%
Total Liabilities
110.9M
↑ 0.92%
FY18Y/Y Change
Total Assets
440.2M
↑ 7.08%
Total Liabilities
121.2M
↑ 9.3%
FY19Y/Y Change
Total Assets
489.5M
↑ 11.22%
Total Liabilities
151.4M
↑ 24.88%
FY20Y/Y Change
Total Assets
500.3M
↑ 2.2%
Total Liabilities
166.3M
↑ 9.83%
FY21Y/Y Change
Total Assets
486.8M
↓ 2.71%
Total Liabilities
147.7M
↓ 11.14%
FY22Y/Y Change
Total Assets
497.7M
↑ 2.26%
Total Liabilities
163.7M
↑ 10.79%
Q2 FY22Q/Q Change
Total Assets
477.7M
↓ 1.29%
Total Liabilities
151.0M
↓ 6.43%
Q3 FY22Q/Q Change
Total Assets
481.2M
↑ 0.73%
Total Liabilities
150.9M
↓ 0.04%
Q4 FY22Q/Q Change
Total Assets
497.7M
↑ 3.44%
Total Liabilities
163.7M
↑ 8.46%
Q1 FY23Q/Q Change
Total Assets
503.2M
↑ 1.09%
Total Liabilities
167.1M
↑ 2.1%
Q2 FY23Q/Q Change
Total Assets
493.5M
↓ 1.92%
Total Liabilities
152.9M
↓ 8.54%
Q3 FY23Q/Q Change
Total Assets
498.1M
↑ 0.93%
Total Liabilities
155.8M
↑ 1.93%
FY17Y/Y Change
Operating Cash Flow
46.7M
↑ 92.75%
Investing Cash Flow
-11.6M
↓ 79.56%
Financing Cash Flow
1000.0
↓ 97.83%
FY18Y/Y Change
Operating Cash Flow
43.2M
↓ 7.42%
Investing Cash Flow
36.6M
↓ 415.73%
Financing Cash Flow
-30.3M
↓ 3025200.0%
FY19Y/Y Change
Operating Cash Flow
65.7M
↑ 51.82%
Investing Cash Flow
-67.5M
↓ 284.7%
Financing Cash Flow
-916.0K
↓ 96.97%
FY20Y/Y Change
Operating Cash Flow
35.9M
↓ 45.36%
Investing Cash Flow
-110.4M
↑ 63.51%
Financing Cash Flow
-20.5M
↑ 2137.34%
FY21Y/Y Change
Operating Cash Flow
42.4M
↑ 18.15%
Investing Cash Flow
-25.7M
↓ 76.7%
Financing Cash Flow
-6.2M
↓ 69.7%
Q2 FY22Q/Q Change
Operating Cash Flow
7.3M
↓ 64.53%
Investing Cash Flow
-10.0M
↑ 152.85%
Financing Cash Flow
-3.4M
↓ 83.13%
Q3 FY22Q/Q Change
Operating Cash Flow
15.1M
↑ 106.1%
Investing Cash Flow
-4.0M
↓ 59.6%
Financing Cash Flow
-20.0K
↓ 99.41%
Q1 FY23Q/Q Change
Operating Cash Flow
20.5M
↑ 153.34%
Investing Cash Flow
-16.9M
-
Financing Cash Flow
-791.0K
↑ 1582.98%
Q2 FY23Q/Q Change
Operating Cash Flow
4.9M
↓ 75.91%
Investing Cash Flow
-26.4M
↑ 55.94%
Financing Cash Flow
-1.5M
↑ 94.69%

Technicals Summary

Sell

Neutral

Buy

Healthstream Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Healthstream Inc
Healthstream Inc
-1.25%
7.66%
0.84%
26.8%
3.77%
10x Genomics Inc
10x Genomics Inc
18.37%
-16.79%
25.1%
-69.3%
-13.27%
Veeva Systems Inc.
Veeva Systems Inc.
-8.82%
-7.55%
6.94%
-34.18%
92.3%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-2.36%
-13.77%
14.75%
14.75%
14.75%
Healthequity Inc
Healthequity Inc
3.27%
17.93%
2.45%
-1.71%
-17.0%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Healthstream Inc
Healthstream Inc
60.0
60.0
6.85
0.44
0.04
0.02
0.0
11.19
10x Genomics Inc
10x Genomics Inc
NA
NA
NA
-2.12
-0.29
-0.12
0.0
6.31
Veeva Systems Inc.
Veeva Systems Inc.
53.18
53.18
1.27
4.18
0.15
0.05
0.0
25.85
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
21.87
21.87
NA
3.82
0.15
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
456.6
456.6
1.92
1.33
0.01
0.02
0.0
22.77
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Healthstream Inc
Healthstream Inc
Buy
$781.4M
3.77%
60.0
4.72%
10x Genomics Inc
10x Genomics Inc
Buy
$5.1B
-13.27%
NA
-37.79%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$28.4B
92.3%
53.18
24.2%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$33.6B
14.75%
21.87
8.91%
Healthequity Inc
Healthequity Inc
Buy
$5.9B
-17.0%
456.6
1.37%

Institutional Holdings

  • BlackRock Inc

    13.02%

  • Vanguard Group Inc

    9.60%

  • Dimensional Fund Advisors, Inc.

    5.15%

  • State Street Corporation

    3.04%

  • Punch & Associates Inv Mgmt Inc

    2.79%

  • Acadian Asset Management LLC

    2.52%

Company Information

thousands of healthcare providers, including half of u.s. hospitals, have chosen healthstream (nasdaq: hstm) as their partner for improving clinical and business outcomes. in this new era of healthcare reform, meaningful use, and value-based purchasing, hundreds of leading organizations each year are switching to healthstream to elevate the role of learning and development in addressing these challenges. our vision healthstream’s vision is to improve the quality of healthcare by assessing and developing the people who deliver care.

Organization
Healthstream Inc
Employees
1135
CEO
Mr. Robert A. Frist Jr.
Industry
Technology Services

Discover More

FAQs